Raymed Labs has informed that the Board of Directors of the Company at its meeting held on May 25, 2015, passed the board formulated, and approved procedure on unpublished price sensitive information (UPSI) as per fair Code of Conduct under regulation 8 and Code of Conduct under regulation 9 of Prohibition of Insider Trading Regulation 2015 affected from May 15, 2015.
The above information is a part of company’s filings submitted to BSE.